A monoclonal antibody activating AdipoR for type 2 diabetes and nonalcoholic steatohepatitis

Adiponectin receptors, AdipoR1 and AdipoR2 are promising targets for the prevention and treatment of metabolic diseases. In this study, we aimed to establish agonistic antibodies against AdipoR1 and AdipoR2 with a long enough half-life to provide a means of improving poor medication adherence associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Asahara, Naomi, Okada-Iwabu, Miki, Iwabu, Masato, Wada, Kouichi, Oka, Kozo, Yamauchi, Toshimasa, Kadowaki, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637737/
https://www.ncbi.nlm.nih.gov/pubmed/37948516
http://dx.doi.org/10.1126/sciadv.adg4216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637737/
https://www.ncbi.nlm.nih.gov/pubmed/37948516
http://dx.doi.org/10.1126/sciadv.adg4216

Ejemplares similares